dipyridamole has been researched along with allopurinol in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (15.00) | 18.7374 |
1990's | 4 (20.00) | 18.2507 |
2000's | 4 (20.00) | 29.6817 |
2010's | 8 (40.00) | 24.3611 |
2020's | 1 (5.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Bergmann, K | 1 |
González, R; Pascual, C; Romay, C | 1 |
Antonopoulos, A; Bacoyannis, C; Beldecos, D; Karvounis, N; Kosmidis, P; Mylonacis, N; Tsavaris, N; Valilis, P; Zamanis, N; Zinelis, A | 1 |
Ehara, M; Noro, T; Ueno, A | 1 |
Kolassa, N; Pfleger, K; Volkmer, I | 1 |
Faderan, MA; Lui, MS; Natsumeda, Y; Weber, G | 1 |
Etienne, MC; Fischel, JL; Formento, P; Haaz, MC; Milano, G; Renée, N | 1 |
Abdel-Ghaffar, MM; Afifi, MA; el-Wakil, HS | 1 |
Busnello, JV; Cunha, A; Kapczinski, F; Lara, DR; Luckenbaugh, DA; Machado-Vieira, R; Marca, G; Soares, JC; Souza, DO; Zarate, CA | 1 |
Danielyan, KE | 1 |
Lähteenvuo, M; Lintunen, J; Taipale, H; Tanskanen, A; Tiihonen, J | 1 |
1 review(s) available for dipyridamole and allopurinol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for dipyridamole and allopurinol
Article | Year |
---|---|
Multimodal biochemical modulation of 5-fluorouracil activity in advanced colorectal cancer with allopurinol, folinic acid and dipyridamol.
Topics: Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colorectal Neoplasms; Dipyridamole; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Humans; Leucovorin; Male; Neoplasm Staging | 1990 |
A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania.
Topics: Acute Disease; Adolescent; Adult; Aged; Allopurinol; Antipsychotic Agents; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Dipyridamole; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Hospitalization; Humans; Lithium Carbonate; Male; Middle Aged; Phosphodiesterase Inhibitors; Severity of Illness Index; Surveys and Questionnaires | 2008 |
17 other study(ies) available for dipyridamole and allopurinol
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Experiments on the medicamental treatment of the noise-induced cochlear damage. Part I. The effect of dipyridamol and allopurinol on the RMP of the cochlea (guinea pig) after noise (author's transl)].
Topics: Allopurinol; Cochlea; Diphosphoglyceric Acids; Dipyridamole; Erythrocytes; Hearing Loss, Noise-Induced; Humans | 1976 |
Drugs effects on superoxide generation and chemiluminescence response of human leukocytes.
Topics: Catechin; Dipyridamole; Ditiocarb; Humans; Hypoxanthine; Hypoxanthines; Leukocytes; Luminescent Measurements; Luminol; Opsonin Proteins; Saccharomyces cerevisiae; Superoxides; Verapamil; Xanthine Oxidase | 1991 |
Study of enzyme inhibitory activities by dipyridamole.
Topics: Carbonic Anhydrase Inhibitors; Dipyridamole; Enzyme Inhibitors; Kinetics; Monoamine Oxidase Inhibitors; Xanthine Oxidase | 1990 |
[Inhibition of adenosine uptake and stimulation of its effect on isolated hearts of warm-blooded animals by coronary active substances].
Topics: Alkaloids; Allopurinol; Animals; Carbon Isotopes; Cocaine; Depression, Chemical; Dipyridamole; Drug Synergism; Ethylenediamines; Guinea Pigs; Heart Rate; In Vitro Techniques; Myocardium; Nitroglycerin; Nucleosides; Ouabain; Papaverine; Prenylamine; Probenecid; Pyridines; Reserpine; Stimulation, Chemical; Theophylline; Triamterene; Vasodilator Agents; Verapamil | 1969 |
Salvage capacity of hepatoma 3924A and action of dipyridamole.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Cells, Cultured; Dipyridamole; Drug Synergism; Guanine Deaminase; Hypoxanthine Phosphoribosyltransferase; Isoxazoles; Liver; Liver Neoplasms, Experimental; Pentosyltransferases; Purine Nucleotides; Pyrimidines; Rats; Xanthine Oxidase | 1983 |
Impact of different fluorouracil biochemical modulators on cellular dihydropyrimidine dehydrogenase.
Topics: Allopurinol; Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Division; Cisplatin; Dihydrouracil Dehydrogenase (NADP); Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Oxidoreductases; Pancreatic Neoplasms; Platelet Aggregation Inhibitors; Tumor Cells, Cultured | 1996 |
A novel chemotherapeutic combination for Trichomonas vaginalis targeting purine salvage pathways of the parasite.
Topics: Allopurinol; Animals; Antimetabolites; Dipyridamole; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Purines; Trichomonas vaginalis; Trichomonas Vaginitis | 2000 |
Dependence of cell survival on correlative activities of xanthine oxidase and dihydopyrimidine dehydrogenase in human brain-derived cell culture.
Topics: Allopurinol; Brain; Cell Survival; Cells, Cultured; Dihydrouracil Dehydrogenase (NADP); Dipyridamole; Dose-Response Relationship, Drug; Humans; Nerve Tissue Proteins; Primary Cell Culture; Purines; Xanthine Oxidase | 2013 |
Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder - A nationwide cohort study.
Topics: Adenosine; Allopurinol; Bipolar Disorder; Calcium Channel Blockers; Cohort Studies; Dihydropyridines; Diltiazem; Dipyridamole; Humans | 2022 |